Adherence to once-daily and twice-daily direct-acting antiviral therapy for hepatitis C infection among people with recent injection drug use or current opioid agonist therapy

Evan B. Cunningham, Behzad Hajarizadeh, Janaki Amin, Alain H. Litwin, Edward Gane, Curtis Cooper, Karine Lacombe, Margaret Hellard, Phillip Read, Jeff Powis, Olav Dalgard, Julie Bruneau, Gail V. Matthews, Jordan J. Feld, John F. Dillon, David Shaw, Philip Bruggmann, Brian Conway, Chris Fraser, Philippa MarksGregory J. Dore, Jason Grebely, SIMPLIFY and D3FEAT study groups

Research output: Contribution to journalArticlepeer-review

19 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Adherence to once-daily and twice-daily direct-acting antiviral therapy for hepatitis C infection among people with recent injection drug use or current opioid agonist therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences